Tirzepatide

Tirzepatide – Research Peptide

Tirzepatide is a novel dual receptor agonist that targets both GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors. It is one of the most advanced and widely studied next-generation peptides in metabolic and obesity research.

Key Research Applications:

Multi-receptor agonism for weight management studies
Investigation of improved glycemic control and insulin sensitivity
Research on appetite regulation and satiety mechanisms
Studies on fat metabolism and body composition
Comparative studies against single GLP-1 agonists (e.g., Semaglutide)
Exploration of cardiovascular and metabolic health benefits

In laboratory research, Tirzepatide has demonstrated superior effects on weight reduction and metabolic improvement compared to single agonists due to its dual mechanism of action.

Technical Specifications:

Purity: ≥99% (HPLC verified)
Form: Lyophilized white powder
Sequence: Synthetic dual GIP/GLP-1 receptor agonist
Molecular Weight: Approximately 4,813 g/mol
Storage: Lyophilized form stable at -20°C. Reconstituted solution should be refrigerated and used within 30 days.

For Research Use Only (RUO)
This product is sold strictly for laboratory and scientific research purposes. It is not for human consumption, therapeutic use, or any veterinary application. Proper laboratory safety protocols must be followed at all times.

Researchers studying metabolic disorders, obesity pharmacology, and incretin-based therapies frequently choose Tirzepatide due to its groundbreaking dual-agonist profile in preclinical and clinical research models. Each vial includes a downloadable Certificate of Analysis (COA) confirming purity and quality.

Why Choose Jartides Tirzepatide?